Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Says Pharma Needs More Than Drugs; Investors May Be Persuaded

Executive Summary

Pharmaceutical companies should diversify their business portfolios to maximize growth, Novartis Head of Corporate Mergers & Acquisitions Nayan Gregory Parekh said Sept. 27

You may also be interested in...



Kindler’s Honeymoon Over? Analysts Press Pfizer Execs On Series Of Stumbles

The sheen of Pfizer's new management team - including CEO Jeffrey Kindler - may be beginning to wear off, based on analyst comments during Pfizer's April 20 first-quarter earnings call

Kindler’s Honeymoon Over? Analysts Press Pfizer Execs On Series Of Stumbles

The sheen of Pfizer's new management team - including CEO Jeffrey Kindler - may be beginning to wear off, based on analyst comments during Pfizer's April 20 first-quarter earnings call

Novartis’ “Captainship” Program Produces More Hypertension Market Share

Nearly a year after introducing its "category captainship" strategy to enhance its leadership position in the market, Novartis is reporting its most successful quarter in the hypertension market

Related Content

UsernamePublicRestriction

Register

PS047665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel